Malaria: new diagnostics for an old problem.

Misdiagnosis of malaria is a frequent mistake that can have deadly consequences. In resource-rich populations, malaria is uncommon and therefore may not be recognized by clinicians who have insufficient training in tropical diseases, or by laboratory technicians who have insufficient experience interpreting blood smears. In these cases, the non-immune victim, typically a recently returned traveler, is at great risk of severe disease and death if infected with Plasmodium falciparum. In resource-poor countries where malaria is a major scourge, patients suffer the opposite problem: clinicians tend to diagnose many if not most febrile illnesses as malaria and often microscopy is not available for confirmation. Recent studies have highlighted the increased mortality by individuals diagnosed with blood smear–negative malaria, presumably because they were not properly treated for whatever disorder other than malaria was causing the fever. In this issue of the journal, Nyunt and others describe their experience using laser desorption mass spectrometry (LDMS) as a new tool for malaria diagnosis in pregnant women. Microscopy has been the standard for malaria diagnosis since not long after Laveran discovered the parasite in 1880, and Romanowsky improved the methods for staining the parasite in 1891. Microscopy has several advantages, including the ability to speciate and quantify the parasites, thereby providing information that is essential for deciding on the proper treatment of the patient. However, microscopy also has several disadvantages that limit its application in different settings. Reading a blood smear is subjective and requires experienced personnel, microscopes are expensive and often reliant on electricity that may not be available, and in the case of pregnancy malaria parasites that are sequestered in the placenta may not be detected by smears prepared using peripheral blood samples. Immunochromatographic assays, also called rapid diagnostic tests or dipsticks, have emerged recently as an alternative to microscopy (reviewed by Moody). These assays typically use a capture antibody and conjugated detection antibody to detect malarial antigen in blood samples. The major benefits of this approach include the rapid turnaround time and the ease of use, which allows inexperienced laboratory or clinical staff to make on-the-spot diagnoses. In cases in which the antigen being detected is secreted or released by the parasite, peripheral blood samples may detect tissue-sequestered parasites even when no parasites are seen on peripheral blood smear. Many dipsticks also allow the user to speciate the offending parasites. However, dipsticks have not yet been developed that allow the user to quantify the parasite burden, which clinicians use to guide and assess therapy. Furthermore, the cost of dipsticks has limited their use. In the past, when commonly used antimalarials such as chloroquine or pyrimethamine-sulfadoxine cost 10–20 U.S. cents for an entire treatment course, many ministries of health decided that the $1 cost (or more) for each dipstick could not be justified. This equation will change in the future, as more expensive combination therapies including artemisinin-containing combination therapy are introduced as first-line regimens to replace treatments that have lost efficacy to drug-resistant parasites. An increased awareness of the cost in human lives of misdiagnosing malaria may also change this equation. Laser desorption mass spectrometry is able to detect heme from hemozoin, the breakdown product of hemoglobin that is commonly referred to as parasite pigment. Importantly, heme from hemozoin yields a spectral signature that is distinct from that of heme from normal hemoglobin, allowing LDMS to discriminate infected from uninfected red blood cells. Although the sensitivity of LDMS to detect heme is theoretically equivalent to that in a single infected red blood cell, the sensitivity in this pioneering study by Nyunt and others was approximately 100–1,000 parasites/ L of blood, or roughly similar to routine microscopy. Optimization of LDMS for malaria diagnosis should improve this level of sensitivity. Nevertheless, in this study LDMS detected parasites in 15 pregnant women (of 45 study volunteers) whose peripheral blood smear yielded negative results on microscopy. Compared with the polymerase chain reaction (PCR), LDMS had a sensitivity of 52% and a specificity of 92%. Notably, an improvement in diagnostic sensitivity may not translate into improved patient care. For example, pregnancy malaria is associated with low birth weight and maternal anemia, outcomes that increase mortality risk for infant and mother. The most sensitive technique for detecting parasites is the PCR. However, whereas maternal parasitemia detected by microscopy is associated with maternal anemia and low birth weight, there was no difference in these outcomes between uninfected women versus women with submicroscopic parasitemia detected by a PCR. Dipsticks are less sensitive than the PCR, and malaria diagnoses obtained by dipstick are associated with pregnancy outcomes, similar to diagnoses obtained by microscopy. Nyunt and others tout LDMS as a tool that is more sensitive than microscopy, is potentially rapid, and requires nothing more than a lancet, blood collection container, and water, after the initial investment in the instrument. The results presented by Nyunt and others suggest that LDMS may be able to provide some quantification of the parasite burden. However, using LDMS to quantify parasitemia will be complicated by mixed species infections; the hemozoin content in ringstage parasites is lower than in mature-stage parasites, and P. falciparum infections yield exclusively ring-stage parasites in the peripheral blood circulation, while the non–P. falciparum species yield all parasite stages. * Address correspondence to Patrick Duffy, Malaria Antigen Discovery Program, Seattle Biomedical Research Institute, Seattle, WA 98109. E-mail: p.duffy@sbri.org Am. J. Trop. Med. Hyg., 73(3), 2005, pp. 482–483 Copyright © 2005 by The American Society of Tropical Medicine and Hygiene

[1]  John M. Pisciotta,et al.  Detection of Plasmodium falciparum in pregnancy by laser desorption mass spectrometry. , 2005, The American journal of tropical medicine and hygiene.

[2]  Chris Drakeley,et al.  Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study , 2004, BMJ : British Medical Journal.

[3]  D. Sullivan,et al.  Rapid detection of malaria infection in vivo by laser desorption mass spectrometry. , 2004, The American journal of tropical medicine and hygiene.

[4]  J. Barnwell,et al.  Evaluation of a malaria rapid diagnostic test for assessing the burden of malaria during pregnancy. , 2004, The American journal of tropical medicine and hygiene.

[5]  P. Duffy,et al.  Drug combinations for malaria: time to ACT? , 2004, The Lancet.

[6]  D. Sullivan,et al.  Detection of malaria parasites in blood by laser desorption mass spectrometry. , 2002, Analytical chemistry.

[7]  S. Rudman,et al.  Evaluation of the OptiMAL Rapid Antigen Test and Species-Specific PCR To Detect Placental Plasmodium falciparum Infection at Delivery , 2002, Journal of Clinical Microbiology.

[8]  F. Mockenhaupt,et al.  Diagnosis of Placental Malaria , 2002, Journal of Clinical Microbiology.

[9]  A. Moody Rapid Diagnostic Tests for Malaria Parasites , 2002, Clinical Microbiology Reviews.

[10]  K. Kain,et al.  Imported malaria: prospective analysis of problems in diagnosis and management. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  H. Laferi,et al.  False positive dipstick test for malaria. , 1997, The New England journal of medicine.

[12]  K. Kain,et al.  Parasight F test compared with the polymerase chain reaction and microscopy for the diagnosis of Plasmodium falciparum malaria in travelers. , 1997, The American journal of tropical medicine and hygiene.